my account
log out
|
|
my account
log out
|
Afuco™ Anti-Human DKK1 ADCC Theraputic Antibody (BHQ880), ADCC Enhanced |
| Create: 08/09/2019 |
| Expired Date: | never |
| Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] |
| Message: | Anti-DKK1 ADCC Enhanced Antibody (BHQ880) is an ADCC enhanced antibody produced by our Afuco™ platform. BHQ880 is a human neutralizing IgG1 anti-DKK1 monoclonal antibody, that is being investigated for its impact on multiple myeloma-related bone disease and as an agent with potential anti-myeloma activity. BHQ880 in combination with zoledronic acid and anti-myeloma therapy was well tolerated and demonstrated potential clinical activity in patients with relapsed or refractory multiple myeloma. https://www.creativebiolabs.net/Anti-DKK1-ADCC-Enhanced-Antibody-BHQ880-20508.htm |
 | |
| City: | Shirley[US]
 |
| Location: |
|
| Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 214 | |
| Feb 01 2023 | GVBE Buffer | 214 | |
| Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 221 | |
| Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 208 | |
| Aug 30 2019 |  | Anti-HSV-2 gH Antibody | 393 |
| Aug 30 2019 | | Anti-L. major LPG Antibody | 476 |
| Aug 30 2019 | | Anti-DENV-1 Antibody | 385 |
| Aug 30 2019 | | Anti-BPV-1 L1 Antibody | 401 |
| Aug 30 2019 | | Anti-H3N2 HA Antibody | 387 |
| Aug 30 2019 | | Anti-EIAV env Antibody | 411 |
| Copyright © toextrade Inc. All rights reserved. Contact us |